Literature DB >> 18159342

Re-examining treatment of latent tuberculosis infection.

B Lynn Johnston1, J M Conly.   

Abstract

Entities:  

Year:  2001        PMID： 18159342      PMCID： PMC2094822          DOI： 10.1155/2001/616419

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN： 1180-2332


× No keyword cloud information.
  34 in total

Review 1.  Tuberculosis: 3. Epidemiology of the disease in Canada.

Authors:  R Long; H Njoo; E Hershfield
Journal:  CMAJ       Date:  1999-04-20       Impact factor: 8.262

2.  Tuberculosis morbidity in a controlled trial of the prophylactic use of isoniazid among household contacts.

Authors:  S H FEREBEE; F W MOUNT
Journal:  Am Rev Respir Dis       Date:  1962-04

Review 3.  Isoniazid-associated hepatitis deaths: a review of available information.

Authors:  D E Snider; G J Caras
Journal:  Am Rev Respir Dis       Date:  1992-02

4.  Isoniazid prophylaxis in contacts of persons with known tuberculosis. Second report.

Authors:  O B Bush; M Sugimoto; Y Fujii; F A Brown
Journal:  Am Rev Respir Dis       Date:  1965-11

5.  Hepatotoxicity associated with isoniazid preventive therapy: a 7-year survey from a public health tuberculosis clinic.

Authors:  C M Nolan; S V Goldberg; S E Buskin
Journal:  JAMA       Date:  1999-03-17       Impact factor: 56.272

6.  Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.

Authors:  N A Halsey; J S Coberly; J Desormeaux; P Losikoff; J Atkinson; L H Moulton; M Contave; M Johnson; H Davis; L Geiter; E Johnson; R Huebner; R Boulos; R E Chaisson
Journal:  Lancet       Date:  1998-03-14       Impact factor: 79.321

Review 7.  Treatment of latent tuberculosis infection: renewed opportunity for tuberculosis control.

Authors:  D L Cohn
Journal:  Clin Infect Dis       Date:  2000-07-25       Impact factor: 9.079

8.  Rifampin preventive therapy for tuberculosis in Boston's homeless.

Authors:  A Polesky; H W Farber; D J Gottlieb; H Park; S Levinson; J J O'Connell; B McInnis; R L Nieves; J Bernardo
Journal:  Am J Respir Crit Care Med       Date:  1996-11       Impact factor: 21.405

9.  Isoniazid prophylaxis among Alaskan Eskimos: a final report of the bethel isoniazid studies.

Authors:  G W Comstock; C Baum; D E Snider
Journal:  Am Rev Respir Dis       Date:  1979-05

10.  Risk for developing tuberculosis among anergic patients infected with HIV.

Authors:  S Moreno; J Baraia-Etxaburu; E Bouza; F Parras; M Pérez-Tascón; P Miralles; T Vicente; J C Alberdi; J Cosín; D López-Gay
Journal:  Ann Intern Med       Date:  1993-08-01       Impact factor: 25.391
View more
  1 in total

1.  Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting.

Authors:  Iukary Takenami; Brook Finkmoore; Almério Machado; Krisztina Emodi; Lee W Riley; Sérgio Arruda
Journal:  Pulm Med       Date:  2012-12-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.